|
 |
AmlodipineThis page contains recent news articles, when available, and an overview of Amlodipine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Amlodipine (when available) Zolmitriptan is a selective 5-hydroxytryptamine receptor subtype agonist indicated for the acute treatment of migraine attacks with or without aura in adults. Zolmitriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine. Zolmitriptan is an agonist for a vascular 5-hydroxytryptamine receptor subtype (probably a member of the 5-HT1D family) having only a weak affinity for 5-HT1A, 5-HT5A, and 5-HT7 receptors and no significant affinity or pharmacological activity at 5-HT2, 5-HT3 or 5-HT4 receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Zolmitriptan also activates 5-HT1 receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Zolmitriptan in humans. For the acute treatment of adult migraine (with or without auras) Mechanism Of Action: Zolmitriptan binds with high affinity to human 5-HT1B and 5-HT1D receptors leading to cranial blood vessel constriction. Current theories proposed to explain the etiology of migraine headache suggest that symptoms are due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of zolmitriptan for the treatment of migraine headache can most likely be attributed to the agonist effects at the 5HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release. News Articles on Zolmitriptan Learning the ABCs of high blood pressure - 04 Jan 2010 The most widely prescribed calcium antagonists are Amlodipine and Felodipine. Last but not the least, we have the Ds for diuretics. ... Philippine Star Cipla in talks to supply drugs to Germany's BI - Dec 15, 2009 As per an industry official, the discussions are for two hypertension drugs — Telmisartan and a combination drug of Amlodipine and Telmisartan. ... Economic Times More price cuts for drugs postponed for 2010 - Dec 16, 2009 These drugs include the Amlodipine for hypertension, Atorvastatin for anti-cholesterol, Azithromycin as antibiotic/antibacterial, Cytarabine and Doxorubicin ... ABS CBN News A roundup of 2009's FDA-approved items - Dec 29, 2009 Twynsta (amlodipine and telmisartan) tablets: This combination drug treats hypertension; it's the marriage of Norvasc with Micardis in a single pill. ... Herald & Review Novartis to Buy Corthera for $120M for Late-Stage Acute Heart-Failure Drug - Dec 23, 2009 Exforge comprises a combination of Diovan and the calcium channel blocker amlodipine. Exforge HCT, which adds a diuretic to the Diovan-amlopidine ... Genetic Engineering News (press release) Dr. Paul Donohue Most acute coughs are caused by viruses - Dec 14, 2009 I take lisinopril and hydrochlorothiazide for blood pressure, Simvastatin for cholesterol and another blood pressure medicine, amlodipine, at night. ... The Detroit News How to control high blood pressure - Dec 17, 2009 The three main groups used as first-line treatment include ACE inhibitors (eg ramipril), calcium channel blockers (eg amlodipine) and a type of water tablet ... WalesOnline Ranbaxy to launch anti-hypertensive drug in Africa - Dec 21, 2009 ...as Olvance in India in April 2009, followed by the August launch of Ol-Vamlo, a fixed-dose combination of Olmesartan Medoxomil with Amlodipine Besylate. Economic Times Novartis set to sustain its leading global position in oncology with portfolio ... - Dec 12, 2009 A combination of aliskiren with the calcium channel blocker amlodipine was filed in the US and is on track to be filed in the EU in 2009, ... PR-USA.net (press release) Cross-breeding leading to native livestock decline in Orissa - Dec 13, 2009 Company supplies generics to the European and UK markets like Amlodipine Maleate, Bendroflumethiazide, Benzhexol (Trihexyphenidyl), Bisacodyl 5mg Tablets, ... TopNews Ayaw uminom ng Amlodipine, na-stroke! - Dec 9, 2009 May pasyente ako na kahit ang presyon niya ay 180 over 110, ayaw pa rin uminom ng Amlodipine. Dahil sa tigas ng kanyang ulo, pagkaraan ng dalawang taon ay ... Philippine Star Ð’ 2009 г. ожидаетÑ?Ñ? 7,6%-ный роÑ?Ñ‚ фармрынка Филиппин в меÑ?тной валюте - Dec 29, 2009 который обÑ?зал Ñ?ократить вдвое цену 5-ти жизненно Ñ?амых важных лекарÑ?тв: amlodipine, atorvastatin, azithromycin, cytarabine и doxorubicin. ... ИИА. Ремедиум 진료패턴ì?„ 바꿀 ìµœì‹ ìž„ìƒ?연구Ⅲ - Dec 27, 2009 ALLHAT연구는 ê³ í˜ˆì••ê³¼ 1ê°œ ì?´ìƒ?ì?˜ 심혈관질환 위험요ì?¸ì?„ ê°–ê³ ìžˆëŠ” 환ìž?를 대ìƒ?으로 암로디핀(amlodipine·칼슘길í•ì œ), 리시노프릴(lisinopril·안지오í…?ì‹ ì „í™˜ 효소 ... KMA Times (ì œì•½ ë ˆë²¨ì—…!)⑦안êµ, `불황ì?€ 없다..íŠ¹í—ˆìŠ¹ì†ŒÂ·ë¹ ë¥¸ì„±ìž¥` - Dec 9, 2009 ...ì?´ 약ì?€ `S-암로디핀과 R-암로디핀ì?´ 50대 50ì?˜ 비율로 혼합ë?œ ë?¼ì„¸ë¯¹(Racemate) 물질ì?¸ 암로디핀(Amlodipine)으로부터 ê³ í˜ˆì•• 치료ì—? 효과가 있는 S-암로디핀 성분 ... 이데일리 Les médicaments du risque cardiovasculaire chez le diabétique de type 2 - Dec 16, 2009 1,09-1,34) ; et à l'amlodipine (réduction du risque d'IC de 28 %, des cas hospitalisés ou fatals de 26 %). Il y avait équivalence entre diurétique, IEC, ... John Libbey Eurotext FDA Approves Telmisartan, Amlodipine Combination Tablets for Hypertension - Oct 19, 2009 NEW YORK -- October 19, 2009 -- The US Food and Drug Administration (FDA) has approved the combination of telmisartan and amlodipine (Twynsta) tablets for ... DG News Generic Name: amlodipine, olmesartan - Nov 11, 2009 Azor (generic name: amlodipine / olmesartan medoxomil) is a new combination medicine used for the treatment of high blood pressure. ... Pattaya Daily News FDA Approves TWYNSTA® (telmisartan plus amlodipine) a New Single Pill ... - Oct 19, 2009 The data for this combination of telmisartan and amlodipine show that it is effective and well tolerated in a range of more complex, difficult-to-treat ... Reuters Baseline Heart Rate, Antihypertensive Treatment, and Prevention of ... - Nov 5, 2009 Conclusions: The authors concluded that there is no evidence for any effect of increased baseline heart rate on the superiority of amlodipine-based over ... Cardiosource FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Oct 19, 2009 The FDA also approved a New Drug Application (NDA) for the combination agent Twynsta® (telmisartan/amlodipine) Tablets for the treatment of hypertension ... Reuters Novartis high blood pressure drug approved in EU - Oct 23, 2009 ...substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of valsartan, amlodipine and HCT, taken either . ... Therapeutics Daily (press release) (registration) Part D Negotiation Will Save Medicare And Seniors Billions - Oct 30, 2009 For example: - Part D plans spend 99.7% more than the VA for the generic form of the hypertension drug Norvasc (amlodipine besylate). ... Medical News Today (press release) GreenMeds Store - norvasc - Oct 31, 2009 Differential roles of ingredient, amlodipine besylate is 10 milligrams once a day anyway! It is important are feeling well. If used for angina a feeling ... Newstalk ZB Canadian Patent Disclosure Requirements Clarified - Oct 20, 2009 The case in question involved a claim to the besylate salt of the pharmaceutical ingredient amlodipine. The patent promised that the besylate salt had ... Mondaq News Alerts (registration) Teva Reports Third Quarter 2009 Results - Nov 2, 2009 ...as well as continued strong sales of generic versions of Lotrel® (amlodipine benazapril), Adderall XR® (amphetamine salts), Yasmin® (drospirenone and ... Reuters Novartis wins EU approval for blood pressure drug - Oct 27, 2009 ...of three widely prescribed blood pressure medications: the angiotensin receptor blocker valsartan, the calcium channel blocker amlodipine, and the HCT. ... Therapeutics Daily (press release) (registration) Boehringer Ingelheim reveals FDA approval of Micardis - Oct 22, 2009 It also announced that its blood pressure reduction treatment Twynsta (telmisartan plus amlodipine) has been granted authorisation. Zenopa Pfizer earnings up 26% despite lower sales of many drugs - Oct 21, 2009 ...down 33% to $82 million and more significantly the blood pressure treatment Norvasc (amlodipine), which fell 13% to $488 million. ... Pharma Times Ranbaxy consolidated net profit at Rs 117 cr in Q3 - Oct 26, 2009 The company launched Ropinirole and received approval for Amlodipine. Europe (including Romania) recorded sales of Rs 327 crore, a de-growth of 10 per cent. ... pharmabiz.com Novartis Gets Approval In European Union For Exforge HCT, New 3-in-1 Treatment ... - Oct 24, 2009 ...pressure medications, namely the angiotensin receptor blocker valsartan, the calcium channel blocker amlodipine, and the diuretic hydrochlorothiazide. ... RTT News Fifty Years of Thiazide Diuretic Therapy for Hypertension - Nov 9, 2009 Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-2428. FREE FULL TEXT 36. ... Archives of Internal Medicine Court Report - Oct 25, 2009 ...in Lipitor® -- and amlodipine besylate -- the active ingredient in Norvasc® -- used to treat high cholesterol in combination with treating hypertension, ... Patent Docs (blog) Solid quarter for Novartis as firm waits for swine flu windfall - Oct 22, 2009 As for Novartis' newer products, the cardiovascular drug Exforge (amlodipine plus valsartan) brought in $171 million, up 49%, while Exjade (deferasirox), ... Pharma Times PRESS RELEASE: Novartis Delivers Strong New -4- - Oct 21, 2009 Exforge (USD 475 million +81% lc), a single pill with the angiotensin receptor blocker Diovan (valsartan) and the calcium channel blocker amlodipine, ... Capital.gr (press release) EXFORGEì?˜ 효능 효과 - Nov 2, 2009 2009ë…„ 추계 심장학회ì—?서는 Amlodipineê³¼ RASì°¨ë‹¨ì œì?˜ ë³µí•©ì œê°€ 혈압강하와 í‘œì ?장기보호ì—? 있어서 얼마나 효과ì ?ì?¸ 약물ì?¸ê°€ì—? 대한 ê°•ì?˜ê°€ 있었다. ... 코리아헬스로그 Novartis: l'UE homologue Exforge HCT pour traiter l'hypertension - Oct 22, 2009 Il s'agit d'un médicament combinant le Diovan (Valsartan), l'Amlodipine et l'Hydrochlorothiazid, ce qui permet une prise unique en un seul comprimé, ... Romandie.com Résumé du jour - Economie - Vendredi 23 octobre 2009 - Oct 23, 2009 Ce médicament du groupe pharmaceutique bâlois représente une combinaison du Diovan (Valsartan), du l'Amlodipine et de l'Hydrochlorothiazid. ... Romandie.com æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...그러나 대표ì ?ì?¸ ì œë„¤ë¦ì?˜ 예로 '암로디핀'(amlodipine)ì?˜ 경우 2007ë…„ 특허만료 후 2008ë…„ 7ì›” 최초ì?˜ ì œë„¤ë¦ì?´ 승ì?¸ë?œ ë’¤ 올 1월까지 34ê°œ 회사ì—?ì„œ 18ê°œ ì œí’ˆì?´ ... 디지틀보사 مريض بالقلب «يكØÙ‘ دماً»بعد المعاشرة بساعة!! - Oct 20, 2009 ...(amlodipine) ومن جهة اخرى Ù?قصر Ù…Ù?عوله يساعد الاطباء على علاج المريض اذا اصيب بجلطة قلبية لا Ø³Ù…Ø Ø§Ù„Ù„Ù‡ خلال تلك العملية وذلك بØرية استخدام النتروجلسرين. ... الرياض ìœ ëŸ½ìœ„ì›?회, 노바티스 '엑스í?¬ì§€ HCT' 허가 - Oct 26, 2009 ...김윤ì˜? 기ìž? 노바티스ì?˜ ê³ í˜ˆì•• ë³µí•©ì œ '엑스í?¬ì§€ HCT'(valsartan-amlodipine-hydrochlorothiazide)ì—? 대해 ìœ ëŸ½ 위ì›?회가 ì‹œíŒ?ì?„ 허가했다. EUì—?서는 엑스í?¬ì§€ HCT를 ... 메디포뉴스 美 '미카르디스+노바스í?¬' ë³µí•©ì œ 승ì?¸ - Oct 19, 2009 ...미êµì—?ì„œ í•ê³ í˜ˆì••ì œ '미카르디스'(Micardis, telmisartan)와 '노바스í?¬'(Norvasc, amlodipine)ì?˜ ë³µí•©ì œì?¸ '트와ì?¸ìŠ¤íƒ€'(Twynsta) ì •ì œê°€ 승ì?¸ì?„ 받았다. ... 디지틀보사 í™”ì?´ìž? 3/4분기 ë¦¬í”¼í† ë“± 거대 품목 매출 ê°?소 - Oct 22, 2009 ...장암 ì¹˜ë£Œì œ *ìº„í† ì‚¬(irinotecan)는 33% ê°?소한 6200만 달러, ê³ í˜ˆì•• ì¹˜ë£Œì œ *노바스í?¬(amlodipine)는 13% ê°?소한 4ì–µ 8800만 달러로 집계ë?˜ì—ˆë‹¤. ... 메디포뉴스 د. عبد الرØيم خاسكية يتØدث عن ارتÙ?اع ضغط الدم - Nov 2, 2009 على سبيل المثال هناك دواء جديد يسمى Exforge يتكون من دوائين ناجØين ومعروÙ?ين هما amlodipine+valsartan .لقد اظهر هذا الدواء نجاØا بعلاج الضغط مع اضرار جانبية ... بانوراما Brand Names/Synonyms: Amlodipine is also known by the following brand names and/or synonymsAMLODIPINE BESYLATE, 99%; Amlocard; Amlodipine; Amlodipine Benzenesulfonate; Amlodipine Besilate; Amlodipine Besylate; Amlodipine Free Base; Amlodipino [Spanish]; Amlodipinum [Latin]; Amlodis; Amvaz; CHEMBANK1767; Coroval; Lipinox; Lotrel; Norvasc Drug Category: Amlodipine is categorized under the following by the FDA: Vasodilator Agents; Antianginal; Antihypertensive Agents; Calcium Channel Blockers; ATC:C08CA01 Dosage Forms: white tablets equivalent to 2.5, 5 and 10 mg Absorption: Amlodipine is slowly and almost completely absorbed from the gastrointestinal tract. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: methylethyl2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
